Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide Alone or With Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma
NCT00833833Phase 2Completed
- Sponsor
- Celgene Corporation
- Start
- Jun 2008
- Primary completion
- Apr 2011
- Modality
- Molecular Glues
- Countries
- 2
01
Overview
A Phase 2 trial of pomalidomide in multiple myeloma (MM), sponsored by Celgene Corporation. Started Jun 2008; status: completed.
02
Drugs
pomalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00833833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833833.